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ZIKA VIRUS: COLLECTION AND SUBMISSION OF 
SPECIMENS FOR ZIKA VIRUS TESTING AT TIME OF BIRTH
General Information 
Laboratory testing for congenital Zika virus infection is 
recommended for infants born to mothers with laboratory 
evidence of Zika virus infection during pregnancy, and for 
infants who have abnormal clinical findings suggestive of 
congenital Zika virus syndrome and a maternal epidemiologic 
link suggesting possible transmission, regardless of maternal 
Zika virus test results. 
For infants born to mothers with risk factors for maternal Zika 
virus infection (travel to or residence in an area of Zika virus 
transmission or sex with a partner with travel to or residence 
in such an area) for whom maternal testing was not performed 
before delivery, assessment of the infant, including comprehensive 
physical exam and careful measurement of head circumference, 
neurologic assessment as well as newborn hearing screen 
should be performed. In addition, based on the level of possible 
maternal Zika virus exposure (e.g., duration and type of exposure, 
use of prevention measures, intensity of Zika virus transmission 
at the location of travel), the provider should consider whether 
further evaluation of the newborn for possible congenital Zika 
virus infection is warranted, in which case a head ultrasound 
and ophthalmologic assessment should be considered. Based 
on results of the evaluation, testing of the infant for Zika virus 
infection could be considered. 
Testing of placental tissue specimens by Zika virus reverse-
transcription polymerase chain reaction (RT-PCR) is conducted 
at CDC’s Infectious Diseases Pathology Branch (IDPB). Zika 
virus RT-PCR on placental tissues from women with possible 
Zika virus exposure can be considered for diagnostic purposes 
for symptomatic pregnant women and women with infants with 
possible Zika virus–associated birth defects without a definitive 
diagnosis of laboratory-confirmed Zika virus infection during 
pregnancy. For asymptomatic pregnant women who have recent 
possible Zika virus exposure but without ongoing possible 
exposure, similar to the updated recommendations for testing of 
non-tissue clinical specimens (e.g., serum and urine), testing of 
placental tissues is not routinely recommended.
Healthcare Providers: 
• Please make sure that your state, territorial, tribal, or local health 
department has been notified and has received pre-approval 
from CDC for submission and shipment of tissue specimens 
before they are collected and sent. 
 » Institutions with surgical pathology available: Please consult 
surgical pathology regarding appropriate collection and 
processing of tissue specimens for Zika virus testing.
 » Institutions without surgical pathology available: Please 
see table below for general guide on collection of tissue 
specimens for Zika virus testing. 
• Specimens should ONLY be sent to CDC directly from health 
departments. CDC’s Zika Pregnancy Hotline (770-488-7100;  
or email zikapregnancy@cdc.gov) is available 24/7 to healthcare 
providers and health departments for consultation regarding 
management of pregnant women and infants with possible 
Zika virus. This hotline can also assist with questions regarding 
specimen submission.
Health Departments: 
• When submitting specimens, please submit CDC Form 50.34 
with all specimens. 
 » Select Test Order Code CDC-10365 “Pathologic Evaluation of 
Tissues for Possible Infectious Etiologies.”
 » Select “Zika Virus” as the suspect agent from the drop  
down menu.
 » The remaining items must be completed electronically and 
then printed. 
• Pre-approval is required prior to submission of all tissue 
specimens (i.e., placenta, umbilical cord). Please contact 
pathology@cdc.gov and eocevent189@cdc.gov. Additional 
clinical and epidemiologic information may be requested, see 
https://www.cdc.gov/zika/laboratories/test-specimens-tissues.
html for minimum required 
information for pre-approval. 
If you have additional 
questions for the Infectious 
Diseases Pathology Branch, 
please call 404-639-3133.
• If you have additional 
questions for the Arboviral 
Diseases Branch, please call 
970-221-6400.
Reporting of Results:
• Test results will be reported to the state 
health department and the submitting healthcare provider. 
Results will not be directly released to patients.
• Turnaround time will depend on testing volume and established 
reporting systems.
Figure: Collecting 
placental specimen
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IMPORTANT: Pre-approval is required prior to submission of any placental or other tissue specimens. 
For pre-approval please contact pathology@cdc.gov and eocevent189@cdc.gov
CDC’s Response to Zika
Specimen Type General  Instructions Notes Storage Shipping
Infant serum
At least 1.0 ml 
Transfer serum to a 
plastic tube measuring 
approximately 50 mm tall 
and 15 mm in diameter 
(e.g., 1.8 mL cryotube or 
2.0 mL microtube) with 
screw cap and secure 
with thermoplastic, self-
sealing lab film.
For antibody and rRT-PCR 
testing, specimens should 
be kept cold (2–6 °C) or 
frozen (-70 °C).
For virus isolation testing, 
specimens should be 
frozen  
as soon as possible  
(-70 °C).
For cold specimens, the 
sample should be placed 
in an insulated container 
with adequate ice packs 
to ensure specimen (“cold 
chain”) integrity. 
For frozen specimens, 
ship the sample on 
enough dry ice to ensure 
specimens remain frozen 
until received.
Arboviral Diseases Branch 
Diagnostic Laboratory 
Centers for Disease 
Control and Prevention 
3156 Rampart Road 
Fort Collins, Colorado 
80521
More information about 
collecting, handling, and 
shipping is available here.
Placenta and fetal 
membranes
At least 2 full thickness 
sections (0.5–1 cm x 3–4 
cm in depth) from middle 
third of placental disk 
and at least 1 from the 
placental disk margin
One 5 x 12 cm strip of 
fetal membranes taken 
from the area of rupture 
and including a small bite 
of the edge of the disk. 
Please include sections 
of the placental disk, 
fetal membranes, and 
pathologic lesions when 
possible. 
(Please reference the 
figure on page one.)
Please sample both 
maternal and fetal side of 
the placenta.  
Label all specimens 
to identify location of 
sample.
Fix specimens in formalin
Volume of formalin  
used should be about 
10x the volume of tissue. 
Place in 10% neutral 
buffered formalin for 3 
days (72 hours). After 
fixation, if not paraffin-
embedded, tissues should 
be transferred to 70% 
ethanol for long term 
storage and shipping.  
Storage and shipping at 
room temperature.
Infectious Diseases 
Pathology Branch 
Centers for Disease 
Control and Prevention 
1600 Clifton Rd. NE, MS 
G-32 
Atlanta GA 30329-4027
Get more instructions 
regarding collecting 
and shipping tissue 
specimens.
Umbilical cord 
At least two representative 
2.5 cm segments of cord 
Label specimen to identify 
location of sample (e.g., 
if proximal, middle, and 
distal to umbilical cord 
insertion site on the 
placenta). 
Fix specimens in formalin 
Volume of formalin used 
should be about 10x 
the volume of tissue. 
Place in 10% neutral 
buffered formalin for 3 
days (72 hours). After 
fixation, if not paraffin-
embedded, tissues should 
be transferred to 70% 
ethanol for long term 
storage and shipping
Storage and shipping at 
room temperature. 
Infectious Diseases 
Pathology Branch  
Centers for Disease 
Control and Prevention 
1600 Clifton Rd. NE, MS 
G-32  
Atlanta GA 30329-4027 
Get more instructions 
regarding collecting 
and shipping tissue 
specimens.
Infant urine
Provide 0.5–1.0 mL 
of the specimen in a 
sterile screw capped vial 
secured with a small piece 
of thermoplastic, self-
sealing lab film. Please 
ensure a tight seal as 
leaking specimens cannot 
be accepted.
Sterile specimen is not 
required
For rRT-PCR testing, 
specimens should be kept 
cold (2–8 °C) or frozen 
(-≤ 20 °C) for storage and 
shipping.
For frozen specimens, 
ship the sample on 
enough dry ice to ensure 
specimens remain frozen 
until received.
Arboviral Diseases Branch 
Diagnostic Laboratory 
Centers for Disease 
Control and Prevention 
3156 Rampart Road 
Fort Collins, Colorado 
80521
Get more information 
about collecting, handling, 
and shipping.
